The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Wall St heads for mixed start, eyes GDP, short-selling

Thu, 28th Jan 2021 13:01

* U.S. GDP snapshot, jobless claims at 1330 GMT

* Dollar gets safe-haven bid as euro backtracks

* Analysts question how far short-selling can last

* European shares wipe out their gains for the year

By Huw Jones

LONDON, Jan 28 (Reuters) - Wall Street headed for mixed
start on Thursday with investors preparing for the latest
snapshot of economic growth and any signs that a big squeeze in
shorted stocks has more to run.

Dow E-minis were up 52 points, or 0.19%, S&P 500
E-minis were off 5 points, or 0.12%. Nasdaq 100 E-minis
were off 50 points, or 0.5%.

U.S. shares saw their sharpest falls in three months on
Wednesday amid a squeeze on hedge funds holding short positions
in stocks like GameStop that are being targetted by an
army of retail buyers.

Investors were seeking refuge in U.S. dollar, with its index
up at 90.72 from a January low of 89.206. Yields on the
10-year U.S. Treasury bond were flat.

The market "smells a bit of blood", but it was unclear how
far the squeeze has to go, said Ned Rumpeltin, European head of
currency strategy at TD Securities. "It does feel like markets
are trying to find a bit of a floor here," he said.

The wait during Wednesday for a statement from the U.S.
Federal Reserve probably kept some investors on the sidelines,
but they would be freer to join in on Thursday, Rumpeltin said.

"What happens as we head into the weekend? All these retail
investors have some spectacular gains on paper - will they be
induced to cut and run and take profits?"

The Commerce Department's snapshot at 1330 GMT of fourth-
quarter gross domestic product in the United States is expected
to show the recovery from the pandemic losing steam as 2020 came
to a close.

U.S. jobless claims for the latest week were also due at
1330 GMT.

Earnings are due from American Airlines, Mastercard,
Macdonalds, Dow Chemicals, JetBlue Airways, Amazon, Mondelez,
and Visa.

Southwest Airlines Co's shares fell in pre-trading
after it reported an annual loss of $3.1 billion, its first
since 1972 as the pandemic stalled demand.

BACK TO SQUARE ONE

European shares wiped out their gains in Europe for the
year, soured by Wednesday's sell-off on Wall Street, no end in
sight to pandemic lockdowns and the squeeze in short positions.

The pan-European STOXX benchmark was down 0.5% at
400.9 points, after hitting its lowest point since December.
London, Paris and Frankfurt were flat
to lower.

"The initial optimism of early this year is starting to
dissipate because of the prospects of tighter pandemic
restrictions for longer, and concerns over 'vaccine
nationalism'," said Michael Hewson, chief market analyst at CMC
Markets.

The European Union, locked in a public spat with vaccine
producer AstraZeneca, wants a shortfall in the company's
supplies to the bloc topped up from production in Britain.

"We could see much more choppiness and much more volatility.
We have a bit of a perfect storm heading into the month end,
which is weighing on equity markets, but I don't think at the
moment we are in a place where it's going to come crashing off,"
Hewson said.

Asian shares slid on Thursday while the safe-haven dollar
rallied as Wall Street's sell-off and delays in coronavirus
vaccines provided an excuse to book profits on recent gains.

MSCI's broadest index of Asia-Pacific shares outside Japan
fell 2%, with valuations looking stretched after
the index rose more than 6% just this month.

The euro eased to $1.2102 amid reports the European
Central Bank felt markets were under-pricing the risk of more
rate cuts.

The bounce in the dollar kept gold prices soft around $1,840
an ounce.

Global demand concerns restrained oil prices despite a drop
in U.S. crude stocks. U.S. crude fell 15 cents to $52.71
a barrel. Brent crude futures dropped to $55.74.

(Additional reporting by Alwyn Scott; editing by Christian
Schmollinger, Ana Nicolaci da Costa, Larry King)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.